Skip to main content
N

NeuroSync

NeuroSync provides a digital health platform that utilizes proprietary algorithms and virtual reality technology to assess brain health and optimize performance in clinical and athletic settings. The platform addresses the lack of validated diagnostics and therapies for neuro health conditions, enabling fast and reliable assessments that enhance patient care and athlete safety.

Boston, United StatesFounded 2022353K+ followers
Updated 4 months ago

Funding

Funding not disclosed

Funding rounds are not available yet.

Founders

Founder details are not available yet.

Product

Problem

A significant portion of the population suffers from neuro health conditions, leading to a substantial economic burden due to the lack of validated, objective diagnostics and therapeutics. Current methods often lack the speed, accuracy, and reliability needed for effective patient care and performance optimization.

Solution

NeuroSync offers a digital health platform that leverages virtual reality (VR) and proprietary algorithms to provide fast, accurate, and reliable assessments of brain health. The platform delivers objective data to clinicians, researchers, and high-performance specialists, enabling them to identify deficits, monitor drug responses, and initiate targeted training. Its customizable technology solutions cater to various neuro health and performance use cases, providing actionable insights for improved patient care and athlete management. The wireless VR-based platform allows for assessments to be conducted anytime, anywhere, enhancing accessibility and convenience.

Target Audience

The primary users include healthcare providers, clinical researchers, sports organizations, and biopharmaceutical companies focused on neuro health and performance.

Features

  • Wireless, VR-based platform for convenient and accessible assessments
  • Proprietary algorithms and quantification methods validated in independent research
  • Assessments can be completed in a minute or less
  • High test-retest reliability (0.9) ensures metric stability
  • Customizable reports for clinicians, researchers, and high-performance specialists
  • AI-driven analytics for identifying deficits and monitoring progress
This profile is AI-generated and may contain inaccuracies.